Intec Pharma Ltd

(NASDAQ:NTEC)

Latest On Intec Pharma Ltd (NTEC):

Date/Time Type Description Signal Details
2021-07-26 20:07 ESTNewsIntec Pharma sinks on reverse share splitN/A
2021-03-18 05:24 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 13:20 ESTEarnings EstimateAn EPS average of -$1.55 is estimated for the 2022 year.Sell
2021-03-17 13:20 ESTEarnings EstimateAn EPS average of -$0.86 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-17 05:01 ESTNewsIntec Pharma (NTEC) shares rocket 87% on merger deal with Decoy BiosystemsN/A
2020-12-10 12:34 ESTAnalyst RatingThe Analyst Target Price has increased from $7.5 to $9.Buy
2020-12-09 22:11 ESTNewsIntec Pharma jumps 65% after research pact with UK-based GW PharmaN/A
2020-11-26 21:00 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 00:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:39 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 12:22 ESTEarnings EstimateAn EPS average of -$0.90 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-05 10:59 ESTNewsIntec Pharma EPS misses by $0.15N/A
2020-11-02 18:19 ESTAnalyst RatingThe Analyst Target Price has increased from $0.38 to $7.5.Buy
2020-10-31 09:29 ESTStock SplitA stock split has occured on Oct 30, 2020 with a split factor of 1:20.Neutral
2020-10-09 05:29 ESTNewsIntec Pharma/MSD ink research deal; shares up 13%N/A
2020-09-26 13:34 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:40 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:38 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 05:27 ESTFinancialsCompany financials have been released.Neutral
2020-08-11 01:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 09:24 ESTAnalyst RatingThe Analyst Target Price has increased from $0.23 to $0.38.Neutral
2020-08-07 23:55 ESTNewsIntec Pharma prices registered direct offeringN/A
2020-08-06 13:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 17:20 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 09:30 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:18 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 09:31 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:14 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:36 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 09:16 ESTEarnings EstimateAn EPS average of -$0.05 is estimated for the quarter ending on September 30, 2020.Buy
2020-06-02 09:16 ESTAnalyst RatingThe Analyst Target Price has decreased from $0.38 to $0.23.Sell
2020-05-27 05:43 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 21:01 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 00:51 ESTNewsIntec Pharma EPS misses by $0.01N/A
2020-05-07 07:11 ESTNewsIntec Pharma secures $5M direct capital raiseN/A
2020-05-06 05:48 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 05:19 ESTFinancialsCompany financials have been released.Neutral
2020-04-12 05:08 ESTNewsIntec Pharma EPS beats by $0.01N/A
2020-04-03 21:18 ESTFinancialsCompany financials have been released.Neutral
2020-03-19 05:11 ESTAnalyst RatingThe Analyst Target Price has decreased from $0.68 to $0.38.Neutral
2020-03-16 05:11 ESTEarnings EstimateAn EPS average of -$0.17 is estimated for the 2021 year.Buy
2020-03-16 05:11 ESTEarnings EstimateAn EPS average of -$0.06 is estimated for the quarter ending on June 30, 2020.Buy
2020-03-14 01:23 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 04:34 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 21:50 ESTFinancialsCompany financials have been released.Neutral

About Intec Pharma Ltd (NTEC):

Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program; and a feasibility agreement with GW Research Limited to explore an undisclosed research program using the Accordion Pill platform. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd in March 2004. Intec Pharma Ltd was founded in 2000 and is based in Jerusalem, Israel.

NTEC Quotes by TradingView

See Advanced Chart

General

  • Name Intec Pharma Ltd
  • Symbol NTEC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:20
  • Last Split Date2020-10-30
  • Fiscal Year EndDecember
  • IPO Date2015-08-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.intecpharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 1.05
  • Enterprise Value EBITDA 0.03
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.71
  • Next Year EPS Estimate -$1.55
  • Next Quarter EPS Estimate -$0.99
  • Return on Assets -41%
  • Return on Equity -108%
  • Earnings Per Share -$1.28
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 22.15 million
  • EBITDA -41806000
  • Analyst Target Price $9
  • Book Value Per Share $4.58
View More

Share Statistics

  • Shares Outstanding 3.95 million
  • Shares Float 3.82 million
  • % Held by Insiders 874%
  • % Held by Institutions 21.82%
  • Shares Short 545490
  • Shares Short Prior Month 517065
  • Short Ratio 0.47
  • Short % of Float 14%
  • Short % of Shares Outstanding 14%
View More

Technicals

  • Beta 1.21
  • 52 Week High $11.2
  • 52 Week Low $2.2
  • 50 Day Moving Average 5.02
  • 200 Day Moving Average 4.45
View More

Dividends

  • Dividend Date 2020-10-30
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Intec Pharma Ltd (NTEC) Dividend Calendar:

NTEC's last dividend payment was made to shareholders on October 30, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Intec Pharma Ltd (NTEC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-17$N/A-$0.53-$0.8537.65%
2020-09-302020-11-05$N/A-$0.95-$0.80-18.75%
2020-06-302020-08-05$N/A-$1.00-$1.000%
2020-03-312020-05-11$N/A-$1.60-$2.0020%
2019-12-312020-03-13$N/A-$1.36-$3.4760.83%
2019-09-302019-11-12$N/A-$6.34-$4.20-50.86%
2019-06-302019-08-09$N/A-$6.00-$5.90-1.69%
2019-03-312019-05-07$N/A-$6.40-$7.3512.93%
2018-12-312019-02-27$N/A-$7.80-$5.90-32.2%
2018-09-302018-11-09$N/A-$5.60-$6.158.94%
2018-06-302018-08-15$N/A-$6.80-$6.27-8.51%
2018-03-312018-05-15$N/A-$8.20-$5.67-44.71%
2017-12-312018-03-09$N/A-$7.80-$7.40-5.41%
2017-09-302017-11-15$N/A-$8.00-$6.80-17.65%
2017-06-302017-08-10$N/A-$0.47-$0.31-51.61%
2017-03-312017-04-07$N/A-$5.80-$6.003.33%
2016-12-312016-12-31$N/A-$0.32-$0.3713.51%
2016-09-302016-09-30$N/A-$0.29-$0.303.33%
2016-06-302016-09-01$N/A-$3.60-$7.4051.35%
2015-12-312016-03-14$N/A-$5.80-$2.00-190%
2015-09-302015-11-05$N/A-$0.16-$0.13-23.08%
2015-06-302015-07-30$N/A-$0.16

Intec Pharma Ltd (NTEC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Intec Pharma Ltd (NTEC) Chart:

Intec Pharma Ltd (NTEC) News:

Below you will find a list of latest news for Intec Pharma Ltd (NTEC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Intec Pharma Ltd (NTEC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Intec Pharma Ltd (NTEC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1638381/999999999520001450/9999999995-20-001450-index.htm
2019-03-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1638381/000000000019004030/0000000000-19-004030-index.htm
2020-06-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1638381/000000000020005291/0000000000-20-005291-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000090266419000920/0000902664-19-000920-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000090266419001011/0000902664-19-001011-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000090266420000973/0000902664-20-000973-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000090266420001124/0000902664-20-001124-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000091957420000832/0000919574-20-000832-index.htm
2020-05-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000091957420003350/0000919574-20-003350-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000092963819000261/0000929638-19-000261-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000110465920010828/0001104659-20-010828-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000110465920011065/0001104659-20-011065-index.htm
2020-02-25SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000110465920024500/0001104659-20-024500-index.htm
2020-05-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000110465920060584/0001104659-20-060584-index.htm
2018-09-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000114420418051200/0001144204-18-051200-index.htm
2019-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000114420419007576/0001144204-19-007576-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000114420419007581/0001144204-19-007581-index.htm
2019-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000117891319000323/0001178913-19-000323-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000117891320000358/0001178913-20-000358-index.htm
2020-11-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000117891320002990/0001178913-20-002990-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019001104/0001213900-19-001104-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019001106/0001213900-19-001106-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019001108/0001213900-19-001108-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019001110/0001213900-19-001110-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019001244/0001213900-19-001244-index.htm
2019-02-12PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019002236/0001213900-19-002236-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019003182/0001213900-19-003182-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1638381/000121390019003211/0001213900-19-003211-index.htm
2019-02-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019003340/0001213900-19-003340-index.htm
2019-03-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1638381/000121390019003422/0001213900-19-003422-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019003544/0001213900-19-003544-index.htm
2019-03-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1638381/000121390019004941/0001213900-19-004941-index.htm
2019-03-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1638381/000121390019005127/0001213900-19-005127-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019005885/0001213900-19-005885-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019005894/0001213900-19-005894-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1638381/000121390019007925/0001213900-19-007925-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019007926/0001213900-19-007926-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019011962/0001213900-19-011962-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019011964/0001213900-19-011964-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019011967/0001213900-19-011967-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019011969/0001213900-19-011969-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019011972/0001213900-19-011972-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019011974/0001213900-19-011974-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019013239/0001213900-19-013239-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019015048/0001213900-19-015048-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1638381/000121390019015050/0001213900-19-015050-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019016791/0001213900-19-016791-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019016793/0001213900-19-016793-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019016936/0001213900-19-016936-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019016939/0001213900-19-016939-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019017280/0001213900-19-017280-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019017461/0001213900-19-017461-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019018080/0001213900-19-018080-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019018235/0001213900-19-018235-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019018237/0001213900-19-018237-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019019181/0001213900-19-019181-index.htm
2019-10-07PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019019888/0001213900-19-019888-index.htm
2019-10-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019021149/0001213900-19-021149-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019022920/0001213900-19-022920-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1638381/000121390019022924/0001213900-19-022924-index.htm
2019-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390019024351/0001213900-19-024351-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019025147/0001213900-19-025147-index.htm
2019-12-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1638381/000121390019025177/0001213900-19-025177-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019025179/0001213900-19-025179-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390019025819/0001213900-19-025819-index.htm
2020-01-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020002157/0001213900-20-002157-index.htm
2020-02-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020002435/0001213900-20-002435-index.htm
2020-02-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020002439/0001213900-20-002439-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020003172/0001213900-20-003172-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020004340/0001213900-20-004340-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020004341/0001213900-20-004341-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020004342/0001213900-20-004342-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020004343/0001213900-20-004343-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020006203/0001213900-20-006203-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1638381/000121390020006334/0001213900-20-006334-index.htm
2020-03-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020006337/0001213900-20-006337-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020011132/0001213900-20-011132-index.htm
2020-05-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020011136/0001213900-20-011136-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020011652/0001213900-20-011652-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020011656/0001213900-20-011656-index.htm
2020-05-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020012942/0001213900-20-012942-index.htm
2020-05-26PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020013459/0001213900-20-013459-index.htm
2020-06-05S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1638381/000121390020014228/0001213900-20-014228-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020014403/0001213900-20-014403-index.htm
2020-06-08DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020014421/0001213900-20-014421-index.htm
2020-06-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1638381/000121390020015082/0001213900-20-015082-index.htm
2020-06-16424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020015118/0001213900-20-015118-index.htm
2020-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020017806/0001213900-20-017806-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020017808/0001213900-20-017808-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020017809/0001213900-20-017809-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020017810/0001213900-20-017810-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020017811/0001213900-20-017811-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020017812/0001213900-20-017812-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020017813/0001213900-20-017813-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020020288/0001213900-20-020288-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020020318/0001213900-20-020318-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020021053/0001213900-20-021053-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020021057/0001213900-20-021057-index.htm
2020-08-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020022527/0001213900-20-022527-index.htm
2020-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020027368/0001213900-20-027368-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020027389/0001213900-20-027389-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020027391/0001213900-20-027391-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000121390020027396/0001213900-20-027396-index.htm
2020-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020029924/0001213900-20-029924-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020030577/0001213900-20-030577-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020033825/0001213900-20-033825-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000121390020035144/0001213900-20-035144-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1638381/000121390020035149/0001213900-20-035149-index.htm
2018-10-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000149315218014251/0001493152-18-014251-index.htm
2020-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1638381/000153561020000065/0001535610-20-000065-index.htm
2018-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418003760/0001615774-18-003760-index.htm
2018-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418003884/0001615774-18-003884-index.htm
2018-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418004038/0001615774-18-004038-index.htm
2018-05-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418004293/0001615774-18-004293-index.htm
2018-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418004591/0001615774-18-004591-index.htm
2018-06-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418005885/0001615774-18-005885-index.htm
2018-06-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418005928/0001615774-18-005928-index.htm
2018-08-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418008118/0001615774-18-008118-index.htm
2018-08-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1638381/000161577418008633/0001615774-18-008633-index.htm
2018-09-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418009744/0001615774-18-009744-index.htm
2018-09-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418009900/0001615774-18-009900-index.htm
2018-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418011137/0001615774-18-011137-index.htm
2018-11-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418012337/0001615774-18-012337-index.htm
2018-11-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418013327/0001615774-18-013327-index.htm
2018-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418013871/0001615774-18-013871-index.htm
2018-12-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418014615/0001615774-18-014615-index.htm
2018-12-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1638381/000161577418014722/0001615774-18-014722-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000090/0001615774-19-000090-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000100/0001615774-19-000100-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000102/0001615774-19-000102-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000103/0001615774-19-000103-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000104/0001615774-19-000104-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000106/0001615774-19-000106-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000107/0001615774-19-000107-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000108/0001615774-19-000108-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000109/0001615774-19-000109-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000110/0001615774-19-000110-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000112/0001615774-19-000112-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000113/0001615774-19-000113-index.htm
2019-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000114/0001615774-19-000114-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1638381/000161577419000266/0001615774-19-000266-index.htm
2019-03-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1638381/999999999519000544/9999999995-19-000544-index.htm
2020-06-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1638381/999999999520001450/9999999995-20-001450-index.htm
2019-03-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1638381/999999999719000955/9999999997-19-000955-index.htm

Intec Pharma Ltd (NTEC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intec Pharma Ltd (NTEC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 874%
Institutional Ownership: 2182%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-08-23JOHN W KOZARICHDirectorBuy100,000.000.4645,900.00151,761.00https://www.sec.gov/Archives/edgar/data/1638381/000121390019016793/0001213900-19-016793-index.htm
2019-08-23Jeffrey A MecklerChief Executive OfficerBuy100,000.000.4645,700.00176,761.00https://www.sec.gov/Archives/edgar/data/1638381/000121390019016791/0001213900-19-016791-index.htm
2019-08-28Jeffrey A MecklerChief Executive OfficerBuy20,000.000.6813,620.00196,761.00https://www.sec.gov/Archives/edgar/data/1638381/000121390019016939/0001213900-19-016939-index.htm
2019-11-19Issac SilbermanDirectorSell1,000.000.50504.004,000.00https://www.sec.gov/Archives/edgar/data/1638381/000121390019024351/0001213900-19-024351-index.htm
2020-02-04Pharma Technologies Ltd. Dexcel10% Share HolderSell110,000.000.2931,900.004,234,897.00https://www.sec.gov/Archives/edgar/data/1638381/000110465920010828/0001104659-20-010828-index.htm
2020-02-03Pharma Technologies Ltd. Dexcel10% Share HolderSell80,000.000.3225,440.004,344,897.00https://www.sec.gov/Archives/edgar/data/1638381/000110465920010828/0001104659-20-010828-index.htm
2020-01-31Pharma Technologies Ltd. Dexcel10% Share HolderSell725,951.000.31224,318.864,424,897.00https://www.sec.gov/Archives/edgar/data/1638381/000110465920010828/0001104659-20-010828-index.htm
2019-08-27ANTHONY J MADDALUNADirectorBuy25,000.000.4711,750.0053,570.00https://www.sec.gov/Archives/edgar/data/1638381/000121390019016936/0001213900-19-016936-index.htm